Comparison of disk diffusion, MIC test strip and broth microdilution methods for cefiderocol susceptibility testing on carbapenem-resistant enterobacterales

Cefiderocol: EUCAST criteria for disc diffusion and broth microdilution for antimicrobial susceptibility testing

(2022) Erika Matuschek et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Contribution of PER-Type and NDM-Type β-Lactamases to Cefiderocol Resistance in Acinetobacter baumannii

(2021) Laurent Poirel et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Cefiderocol: A new cephalosporin stratagem against multidrug resistant gram-negative bacteria

(2021) Sharon Ong’uti et al.   CLINICAL INFECTIOUS DISEASES

Clinical Pharmacokinetics and Pharmacodynamics of Cefiderocol

(2021) Muhammad Bilal et al.   CLINICAL PHARMACOKINETICS

Progressive Development of Cefiderocol Resistance in Escherichia coli During Therapy is Associated With an Increase in blaNDM-5 Copy Number and Gene Expression

(2021) Patricia J Simner et al.   CLINICAL INFECTIOUS DISEASES

Cefiderocol Antimicrobial Susceptibility Testing Considerations: The Achilles Heel of the Trojan Horse?

(2020) Patricia J. Simner et al.   JOURNAL OF CLINICAL MICROBIOLOGY

In vitro activity of cefiderocol, a siderophore-cephalosporin, against multidrug-resistant gram-negative bacteria

(2020) Shazad Mushtaq et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Cefiderocol Antimicrobial Susceptibility Testing against Multidrug-Resistant Gram-negative Bacilli: A Comparison of Disk Diffusion to Broth Microdilution

(2020) C. Paul Morris et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Reproducibility of broth microdilution MICs for the novel Siderophore cephalosporin, Cefiderocol, determined using Iron-depleted cation-adjusted Mueller-Hinton broth

(2019) Meredith A. Hackel et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE